◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Lee's Pharmaceutical Holdings Limited (0950) Financial History

Name: Lee's Pharmaceutical Holdings Limited (0950) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-10

Lee's Pharmaceutical Holdings Limited (0950) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Sha Tin, Hong Kong with about 1,094 employees. Its market capitalization is roughly HKD 642 million. In the fiscal year ended 2025-12-31, 0950 reported HKD 1.4B in revenue and HKD 92M in net income.

Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.

Interactive charts & full statements →

0950 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	HKD 1.4B	HKD 1.4B	HKD 1.1B	HKD 1.2B	—
Gross Profit	HKD 730M	HKD 753M	HKD 551M	HKD 771M	—
Operating Income (EBIT)	HKD 76M	HKD 77M	(HKD 7M)	HKD 76M	—
Net Income	HKD 92M	HKD 93M	HKD 17M	HKD 51M	—

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0950 Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(HKD 28M)	(HKD 18M)	(HKD 11M)	(HKD 24M)	—

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0950 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	HKD 3.5B	HKD 2.6B	HKD 2.9B	HKD 2.8B	—
Total Liabilities	HKD 1.6B	HKD 1.1B	HKD 930M	HKD 940M	—

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0950 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

ESPR · Esperion Therapeutics Inc — $819 million
1652 · Fusen Pharmaceutical Company Limited — $784 million
0239 · Pak Fah Yeow International Limited — $732 million
IRWD · Ironwood Pharmaceuticals, Inc. — $712 million
WEED · Canopy Growth Corporation — $619 million
EVT · Evotec SE — $612 million
3737 · Zhongzhi Pharmaceutical Holdings Limited — $578 million
TLRY · Tilray Brands, Inc. — $578 million

← 0948 All “0-9” companies 0951 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.